Promethazin Domesco

Promethazin Domesco may be available in the countries listed below.

Ingredient matches for Promethazin Domesco

Promethazine

Promethazine is reported as an ingredient of Promethazin Domesco in the following countries:

• Vietnam

International Drug Name Search

Captopril Fariberica

Captopril Fariberica may be available in the countries listed below.

Ingredient matches for Captopril Fariberica

Captopril

Captopril is reported as an ingredient of Captopril Fariberica in the following countries:

• Portugal

International Drug Name Search

Flucloxacillin OrPha

Flucloxacillin OrPha may be available in the countries listed below.

Ingredient matches for Flucloxacillin OrPha

Flucloxacillin

Flucloxacillin sodium salt (a derivative of Flucloxacillin) is reported as an ingredient of Flucloxacillin OrPha in the following countries:

• Switzerland

International Drug Name Search

Striaton

Striaton may be available in the countries listed below.

Ingredient matches for Striaton

Carbidopa

Carbidopa monohydrate (a derivative of Carbidopa) is reported as an ingredient of Striaton in the following countries:

• Germany

Levodopa

Levodopa is reported as an ingredient of Striaton in the following countries:

• Germany

International Drug Name Search

Synclar

Synclar may be available in the countries listed below.

Ingredient matches for Synclar

Clarithromycin

Clarithromycin is reported as an ingredient of Synclar in the following countries:

• Latvia

International Drug Name Search

Malarone Pediatric

See also: Generic Malarone

Malarone Pediatric is a brand name of atovaquone/proguanil, approved by the FDA in the following formulation(s):

MALARONE PEDIATRIC (atovaquone; proguanil hydrochloride - tablet; oral)

• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: July 14, 2000
  
  Strength(s): 62.5MG;25MG
  

Has a generic version of Malarone Pediatric been approved?

No. There is currently no therapeutically equivalent version of Malarone Pediatric available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Malarone Pediatric. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Combination of atovaquone with proguanil for the treatment of protozoal infections
  Patent 5,998,449
  Issued: December 7, 1999
  Inventor(s): Gutteridge; Winston Edward & Hutchinson; David Brian Ashton & Latter; Victoria Susan & Pudney; Mary
  Assignee(s): Glaxo Wellcome Inc.
  The invention relates to combinations of atovaquone and proguanil, their use in the treatment and propinylaxis of parasitic infections, such as protozoal parasitic infections, e.g. malaria and toxoplasmosis, and infections caused by P.carinii and their use in the manunfacture of medicaments for the treatment and/or prophylaxis of such infections. The combinations can conveniently be administered in a single pharmaceutical formulation. Preferably, atovaquone and proguanil are administered in a potentiating ratio so that they act in synergy.
  
  Patent expiration dates:
  
  
  • November 25, 2013
    
    ✓ 
    Patent use: TREATMENT OF PROTOZOAL INFECTION
  
  
  
  • May 25, 2014
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Combination of atovaquone with proguanil for the treatment of protozoal infections
  Patent 6,166,046
  Issued: December 26, 2000
  Inventor(s): Gutteridge; Winston Edward & Hutchinson; David Brian Ashton & Latter; Victoria Susan & Pudney; Mary
  Assignee(s): Glaxo Wellcome Inc.
  The invention relates to combinations of atovaquone and proguanil, their use in the treatment and prophylaxis of parasitic infections such as protozoal parasitic infections, e.g., malaria and toxoplasmosis, and infections caused by P. carinii and their use in the manufacture of medicaments for the treatment and/or prophylaxis of such infections. The combinations can conveniently be administered in a single pharmaceutical formulation. Preferably, atovaquone and proguanil are administered in a potentiating ratio so that they act in synergy.
  
  Patent expiration dates:
  
  
  • November 25, 2013
    
  
  
  
  • May 25, 2014
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Preventing protozoal infections
  Patent 6,291,488
  Issued: September 18, 2001
  Inventor(s): Gutteridge; Winston Edward & Hutchinson; David Brian Ashton & Latter; Victoria Susan & Pudney; Mary
  Assignee(s): Glaxo Wellcome Inc.
  The invention relates to combinations of atovaquone and proguanil, their use in the treatment and prophylaxis of parasitic infections such as protozoal parasitic infections, e.g., malaria and toxoplasmosis, and infections caused by P. carinii and their use in the manufacture of medicaments for the treatment and/or prophylaxis of such infections. The combinations can conveniently be administered in a single pharmaceutical formulation. Preferably, atovaquone and proguanil are administered in a potentiating ratio so that they act in synergy.
  
  Patent expiration dates:
  
  
  • November 25, 2013
    
    ✓ 
    Patent use: METHOD OF USE OF ATOVAQUONE AND PROGUANIL
  
  
  
  • May 25, 2014
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Malarone Pediatric Consumer Information (Cerner Multum)
• Malarone Pediatric Advanced Consumer Information (Micromedex)
• Atovaquone/Proguanil Consumer Information (Wolters Kluwer)
• Atovaquone and proguanil Consumer Information (Cerner Multum)
• Atovaquone and chloroguanide Advanced Consumer Information (Micromedex)
• Atovaquone and proguanil Advanced Consumer Information (Micromedex)
• Atovaquone and Proguanil Hydrochloride AHFS DI Monographs (ASHP)

Flutizal

Flutizal may be available in the countries listed below.

Ingredient matches for Flutizal

Fluticasone

Fluticasone propionate (a derivative of Fluticasone) is reported as an ingredient of Flutizal in the following countries:

• Greece

International Drug Name Search

Gasperazine D

Gasperazine D may be available in the countries listed below.

Ingredient matches for Gasperazine D

Famotidine

Famotidine is reported as an ingredient of Gasperazine D in the following countries:

• Japan

International Drug Name Search

Pair

Pair may be available in the countries listed below.

Ingredient matches for Pair

Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Pair in the following countries:

• Bangladesh

International Drug Name Search